Home > Balance Sheet > VENUS REMEDIES

VENUS REMEDIES
Contingent Liabilities

    Back to Balance Sheet
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Contingent Liabilities ₹20 Cr₹38 Cr₹30 Cr₹40 Cr₹11 Cr

What is the latest Contingent Liabilities ratio of VENUS REMEDIES ?

The latest Contingent Liabilities ratio of VENUS REMEDIES is ₹20 Cr based on Mar2026 Consolidated results.
Year Contingent Liabilities
Mar2026₹20 Cr
Mar2025₹38 Cr
Mar2024₹30 Cr
Mar2023₹40 Cr
Mar2022₹11 Cr

How is Contingent Liabilities of VENUS REMEDIES Trending?

Years Contingent Liabilities % Change
Mar2026 ₹20 Cr
-48.00
Mar2025 ₹38 Cr
25.48
Mar2024 ₹30 Cr
-23.13
Mar2023 ₹40 Cr
272.42
Mar2022 ₹11 Cr -

Compare Contingent Liabilities of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹2,093.6 Cr -1.5% -12.2% 200.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹466,431.0 Cr -2.6% 2.4% 14.6% Stock Analytics
DIVIS LABORATORIES ₹220,115.0 Cr 6.5% 23.3% 25.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,853.0 Cr 2.6% 3% 33.5% Stock Analytics
CIPLA ₹119,158.0 Cr -1.1% -0.2% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹98,074.4 Cr 2.6% -13.3% -10.7% Stock Analytics


VENUS REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

-1.5%

-12.2%

200.9%

SENSEX

1.3%

1%

-2.9%


You may also like the below Video Courses